A vaccine against the plague? This Maryland company is on it

A subsidiary of Falls Church-based government IT firm CSRA Inc. (NYSE: CSRA) has received a nod from the Food and Drug Administration for the vaccine it is developing against the bubonic plague. Yes, the plague. Frederick-based DynPort Vaccine Company LLC was granted Orphan Drug Designation from the FDA for the vaccine it is creating for the U.S. Department of Defense. It is intended for pre-exposure prophylaxis to combat the infection from Yersinia pestis, which is the causative agent o f the bubonic…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news